Status:
RECRUITING
Treatment of Temporomandibular Disorders in Children and Adolsecents
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Folktandvården Stockholms län AB
Conditions:
Temporomandibular Disorder
Myalgia
Eligibility:
All Genders
7-13 years
Phase:
NA
Brief Summary
Children and adolescents are treated with routine treatment approaches for adults and one of the most commonly used treatments are occlusal appliances. The use of occlusal appliances in managing orofa...
Detailed Description
It is well known that the impact of pain in the orofacial region is not only the unpleasant sensory experience but also an emotional experience with feelings of failure, misery, guilt, alienation, and...
Eligibility Criteria
Inclusion
- age 7-14 years
- a diagnosis of myalgia or arthralgia according to DC/TMD
- self-assessed average TMD pain intensity of ≥ 30 mm on a 100-mm visual analogue scale (VAS) during one week prior to examination.
- The patients will remain included with one or several co-diagnoses of:
- disc displacement with or without reduction according to DC/TMD
- degenerative joint disease.
Exclusion
- diagnosed systemic muscular or joint diseases (e.g. fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis)
- whiplash associated disorder (WAD)
- neuropathic pain or neurological disorders (e.g. myasthenia gravis, orofacial dystonia)
- history of psychiatric disorders, and 5) pain of dental origin.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03849534
Start Date
September 1 2024
End Date
December 31 2028
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet, Department of Dental Medicine
Huddinge, Sweden, 141 04